DNA methylation signature (SAM40) identifies subgroups of the Luminal A breast cancer samples with distinct survival

Thomas Fleischer , Jovana Klajic , Miriam Ragle Aure , Riku Louhimo , Arne Pladsen , Lars Ottestad , Nizar Touleimat (1) , Marko Laakso , Ann Rita Halvorsen , Grethe Alnæs , Margit L.H. Riis , Åslaug Helland , Sampsa Hautaniemi , Per Eystein Lønning , Bjorn Naume (2) , Anne-Lise Børresen-Dale (3) , Jörg Tost (4) , Vessela Kristensen

1 IBISC - Informatique, Biologie Intégrative et Systèmes Complexes
2 Department of Oncology, The Norwegian Radium Hospital
3 UiO - University of Oslo
4 Laboratory for Epigenetics and Environment

Domains: Statistics [stat]; Machine Learning [stat.ML]; Applications [stat.AP]; Life Sciences [q-bio]; Cellular Biology; Biochemistry, Molecular Biology; Quantitative Methods [q-bio.QM]; Genetics; Cancer; Human health and pathology

Thomas Fleischer, Jovana Klajic, Miriam Ragle Aure, Riku Louhimo, Arne Pladsen, et al.. DNA methylation signature (SAM40) identifies subgroups of the Luminal A breast cancer samples with distinct survival. Oncotarget, 2017, 8 (1), ⟨10.18632/oncotarget.13718⟩. ⟨cea-01833188⟩